Association of the thrombomodulin gene c.1418c7gt;t polymorphism with thrombomodulin levels and with venous thrombosis risk

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 6, 2013, Pages 1435-1440

  Navarro, Silvia ^a,e   Medina, Pilar ^a,e   Bonet, Elena ^a   Corral, Javier ^b   Martínez Sales, Vicenta ^a   Martos, Laura ^a,e   Rivera, Miguel ^a   Roselló Lletí, Esther ^a   Alberca, Ignacio ^c   Roldan, Vanessa ^b   Mira, Yolanda ^a   Ferrando, Fernando ^a   Estellés, Amparo ^a   Vicente, Vicente ^b   Bertina, Rogier M ^d   España, Francisco ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e RECAVA ^*  (Spain)

Author keywords

Endothelial cells; Gene expression; Prote in C; Thrombomodulin; Venous thrombosis

Indexed keywords

ACTIVATED PROTEIN C; MESSENGER RNA; THROMBIN; THROMBOMODULIN;

ADULT; ARTICLE; CELL ISOLATION; CELL LYSATE; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; RISK REDUCTION; UMBILICAL CORD; UMBILICAL VEIN ENDOTHELIAL CELL; VENOUS THROMBOEMBOLISM;

ENDOTHELIAL CELLS; GENE EXPRESSION; PROTEIN C; THROMBOMODULIN; VENOUS THROMBOSIS;

ADULT; ALLELES; CASE-CONTROL STUDIES; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEIN C; REFERENCE VALUES; RISK ASSESSMENT; RNA, MESSENGER; SOLUBILITY; THROMBOMODULIN; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84879080216     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.301360     Document Type: Article

References (36)

1. Souto JC, Almasy L, Borrell M, Garí M, Martínez E, Mateo J, Stone WH, Blangero J, Fontcuberta J. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation. 2000;101:1546-1551.
2. Heit JA, Phelps MA, Ward SA, Slusser JP, Petterson TM, De Andrade M. Familial segregation of venous thromboembolism. J Thromb Haemost. 2004;2:731-736.
3. Soria JM, Navarro S, Medina P, Souto R, Buil A, Estellés A, Fontcuberta J, España F. Heritability of plasma concentrations of activated protein C in a Spanish population. Blood Coagul Fibrinolysis. 2009;20:17-21.
4. Esmon CT. The endothelial cell protein C receptor. Thromb Haemost. 2000;83:639-643.
5. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest. 1981;68:1370-1373.
6. Esmon CT, Fukudome K, Mather T, Bode W, Regan LM, Stearns-Kurosawa DJ, Kurosawa S. Inflammation, sepsis, and coagulation. Haematologica. 1999;84:254-259.
7. Espana F, Medina P, Navarro S, Zorio E, Estellés A, Aznar J. The multifunctional protein C system. Curr Med Chem Cardiovasc Hematol Agents. 2005;3:119-131.
8. Ikezoe T, Yang J, Nishioka C, Honda G, Furihata M, Yokoyama A. Thrombomodulin protects endothelial cells from a calcineurin inhibitorinduced cytotoxicity by upregulation of extracellular signal-regulated kinase/myeloid leukemia cell-1 signaling. Arterioscler Thromb Vasc Biol. 2012;32:2259-2270.
9. Li JY, Su CH, Wu YJ, Tien TY, Hsieh CL, Chen CH, Tseng YM, Shi GY, Wu HL, Tsai CH, Lin FY, Yeh HI. Therapeutic angiogenesis of human early endothelial progenitor cells is enhanced by thrombomodulin. Arterioscler Thromb Vasc Biol. 2011;31:2518-2525.
10. Weiler-Guettler H, Christie PD, Beeler DL, Healy AM, Hancock WW, Rayburn H, Edelberg JM, Rosenberg RD. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin Invest. 1998;101:1983-1991.
11. Isermann B, Hendrickson SB, Zogg M, Wing M, Cummiskey M, Kisanuki YY, Yanagisawa M, Weiler H. Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis. J Clin Invest. 2001;108:537-546.
12. Raife TJ, Dwyre DM, Stevens JW, Erger RA, Leo L, Wilson KM, Fernández JA, Wilder J, Kim HS, Griffin JH, Maeda N, Lentz SR. Human thrombomodulin knock-in mice reveal differential effects of human thrombomodulin on thrombosis and atherosclerosis. Arterioscler Thromb Vasc Biol. 2011;31:2509-2517.
13. Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest. 1985;76:2178-2181.
14. Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodulin in health and diseases. Blood. 1990;76:2024-2029.
15. Ohlin AK, Larsson K, Hansson M. Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma. J Thromb Haemost. 2005;3:976-982.
16. Loreth RM, Seus Ch, Berger HH, Albert FW. Plasma thrombomodulin concentrations in healthy persons depends on age and sex. Ann Hematol. 1997;74(suppl II):A89 (Abstract).
17. Amiral J, Adam M, Mimilla F, Larrivaz I, Chambrette B, Boffa MC. Design and validation of a new immunoassay for soluble forms of thrombomodulin and studies on plasma. Hybridoma. 1994;13:205-213.
18. Weiler H, Isermann BH. Thrombomodulin. J Thromb Haemost. 2003;1:1515-1524.
19. van der Velden PA, Krommenhoek-Van Es T, Allaart CF, Bertina RM, Reitsma PH. A frequent thrombomodulin amino acid dimorphism is not associated with thrombophilia. Thromb Haemost. 1991;65:511-513.
20. Ohlin AK, Marlar RA. The first mutation identified in the thrombomodulin gene in a 45-year-old man presenting with thromboembolic disease. Blood. 1995;85:330-336.
21. Medina P, España F, Villa P, Vayá A, Mira Y, Estellés A, Royo M, Bertina RM, Aznar J. The C1418T polymorphism in the thrombomodulin gene is associated with increased levels of circulating activated protein C. J Thromb Haemost. 2005;3:P1328.
22. Aleksic N, Folsom AR, Cushman M, Heckbert SR, Tsai MY, Wu KK. Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma thrombomodulin, and incidence of venous thromboembolism: the LITE Study. J Thromb Haemost. 2003;1:88-94.
23. Heit JA, Petterson TM, Owen WG, Burke JP, DE Andrade M, Melton LJ 3rd. Thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population-based case-control study. J Thromb Haemost. 2005;3:710-717.
24. Ireland H, Kunz G, Kyriakoulis K, Stubbs PJ, Lane DA. Thrombomodulin gene mutations associated with myocardial infarction. Circulation. 1997;96:15-18.
25. Norlund L, Holm J, Zöller B, Ohlin AK. A common thrombomodulin amino acid dimorphism is associated with myocardial infarction. Thromb Haemost. 1997;77:248-251.
26. Wu KK, Aleksic N, Ahn C, Boerwinkle E, Folsom AR, Juneja H; Atherosclerosis Risk in Communities Study (ARIC) Investigators. Thrombomodulin Ala455Val polymorphism and risk of coronary heart disease. Circulation. 2001;103:1386-1389.
27. Konstantoulas CJ, Cooper J, Warnock G, Miller GJ, Humphries SE, Ireland H. A combination of two common thrombomodulin gene variants (-1208-1209TTdelTT and A455V) influence risk of coronary heart disease: a prospective study in men. Atherosclerosis. 2004;177: 97-104.
28. Nilsson TK, Hellsten G, Amiral J. Plasma thrombomodulin concentrations in relation to cardiovascular risk factors in a population sample. Blood Coagul Fibrinolysis. 1993;4:455-458.
29. España F, Vayá A, Mira Y, Medina P, Estellés A, Villa P, Falcó C, Aznar J. Low level of circulating activated protein C is a risk factor for venous thromboembolism. Thromb Haemost. 2001;86:1368-1373.
30. Qu D, Wang Y, Song Y, Esmon NL, Esmon CT. The Ser219->Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype. J Thromb Haemost. 2006;4:229-235.
31. Medina P, Navarro S, Corral J, Zorio E, Roldán V, Estellés A, Santamaría A, Marín F, Rueda J, Bertina RM, España F; RECAVA Thrombosis Groups. Endothelial protein C receptor polymorphisms and risk of myocardial infarction. Haematologica. 2008;93: 1358-1363.
32. Sugiyama S, Hirota H, Kimura R, Kokubo Y, Kawasaki T, Suehisa E, Okayama A, Tomoike H, Hayashi T, Nishigami K, Kawase I, Miyata T. Haplotype of thrombomodulin gene associated with plasma thrombomodulin level and deep vein thrombosis in the Japanese population. Thromb Res. 2007;119:35-43.
33. Nakabayashi M, Yamamoto S, Suzuki K. Analysis of thrombomodulin gene polymorphism in women with severe early-onset preeclampsia. Semin Thromb Hemost. 1999;25:473-479.
34. Jackson DE, Tetaz TJ, Salem HH, Mitchell CA. Purification and characterization of two forms of soluble thrombomodulin from human urine. Eur J Biochem. 1994;221:1079-1087.
35. Auro K, Komulainen K, Alanne M, Silander K, Peltonen L, Perola M, Salomaa V. Thrombomodulin gene polymorphisms and haplotypes and the risk of cardiovascular events: a prospective follow-up study. Arterioscler Thromb Vasc Biol. 2006;26:942-947.
36. Strandberg K, Svensson PJ, Ohlin AK. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity. Thromb Res. 2007;121:145-151.